Microglia-specific interleukin-4 delivery by engineered extracellular vesicles restores inner blood-retinal barrier in diabetic retinopathy via GAS6-MERTK pathway.

J Nanobiotechnology · 2025 · PMC12860109 · PMID 41462307

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, these effects were reduced by IL4@CHHSSSARC-EV treatment, and the difference was highly significant compared to IL4 + EV and IL4@EV groups (Fig. 7 A, Additional Fig. 7 A).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.